Importer of Controlled Substances; Notice of Registration, 56613 [E8-22882]
Download as PDF
Federal Register / Vol. 73, No. 189 / Monday, September 29, 2008 / Notices
the basic class of controlled substance
listed.
Dated: September 22, 2008.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
[FR Doc. E8–22878 Filed 9–26–08; 8:45 am]
BILLING CODE 4410–09–P
Drug Enforcement Administration
Importer of Controlled Substances;
Notice of Registration
Drug Enforcement Administration
Importer of Controlled Substances;
Notice of Registration
By Notice dated March 11, 2008 and
published in the Federal Register on
March 19, 2008 (73 FR 14839), AllTech
Associates Inc., 2051 Waukegan Road,
Deerfield, Illinois 60015, made
application to the Drug Enforcement
Administration (DEA) to be registered as
an importer of the basic classes of
controlled substances listed in schedule
II:
Drug
Schedule
mstockstill on PROD1PC66 with NOTICES
Cocaine (9041) .............................
Codeine (9050) .............................
Hydrocodone (9193) .....................
Meperidine (9230) ........................
Methadone (9250) ........................
Morphine (9300) ...........................
II
II
II
II
II
II
The company plans to import these
controlled substances for the
manufacture of reference standards.
No comments or objections have been
received. DEA has considered the
factors in 21 U.S.C. 823(a) and 952(a)
and determined that the registration of
AllTech Associates Inc. to import the
basic classes of controlled substances is
consistent with the public interest and
with United States obligations under
international treaties, conventions, or
protocols in effect on May 1, 1971, at
this time. DEA has investigated AllTech
Associates Inc. to ensure that the
company’s registration is consistent
with the public interest. The
investigation has included inspection
and testing of the company’s physical
security systems, verification of the
company’s compliance with state and
local laws, and a review of the
company’s background and history.
Therefore, pursuant to 21 U.S.C. 952(a)
and 958(a), and in accordance with 21
CFR 1301.34, the above named company
is granted registration as an importer of
the basic classes of controlled
substances listed.
16:48 Sep 26, 2008
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
DEPARTMENT OF JUSTICE
VerDate Aug<31>2005
Dated: September 22, 2008.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
[FR Doc. E8–22880 Filed 9–26–08; 8:45 am]
Jkt 214001
By Notice dated June 19, 2008 and
published in the Federal Register on
June 27, 2008 (73 FR 36572), Aptuit,
10245 Hickman Mills Drive, Kansas
City, Missouri 64137, made application
by renewal to the Drug Enforcement
Administration (DEA) to be registered as
an importer of Marihuana (7360), a basic
class of controlled substance listed in
schedule I.
The company plans to import a
finished pharmaceutical product
containing cannabis extracts in dosage
form for packaging for a clinical trial
study.
No comments or objections have been
received. DEA has considered the
factors in 21 U.S.C. 823(a) and 952(a)
and determined that the registration of
Aptuit to import the basic class of
controlled substance is consistent with
the public interest, and with United
States obligations under international
treaties, conventions, or protocols in
effect on May 1, 1971, at this time. DEA
has investigated Aptuit to ensure that
the company’s registration is consistent
with the public interest. The
investigation has included inspection
and testing of the company’s physical
security systems, verification of the
company’s compliance with state and
local laws, and a review of the
company’s background and history.
Therefore, pursuant to 21 U.S.C. 952(a)
and 958(a), and in accordance with 21
CFR 1301.34, the above named company
is granted registration as an importer of
the basic class of controlled substance
listed.
Dated: September 22, 2008.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
[FR Doc. E8–22881 Filed 9–26–08; 8:45 am]
BILLING CODE 4410–09–P
PO 00000
Frm 00073
Fmt 4703
Sfmt 4703
56613
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Importer of Controlled Substances;
Notice of Registration
By Notice dated June 19, 2008 and
published in the Federal Register on
June 27, 2008 (73 FR 36571), Aptuit
(Allendale) Inc., 75 Commerce Drive,
Allendale, New Jersey 07401, made
application by renewal to the Drug
Enforcement Administration (DEA) to
be registered as an importer of
Noroxymorphone (9668), a basic class of
controlled substance listed in schedule
II.
The company plans to import the
basic class of controlled substance for
clinical trials and research.
No comments or objections have been
received. DEA has considered the
factors in 21 U.S.C. 823(a) and 952(a)
and determined that the registration of
Aptuit (Allendale) Inc. to import the
basic classes of controlled substances is
consistent with the public interest, and
with United States obligations under
international treaties, conventions, or
protocols in effect on May 1, 1971, at
this time. DEA has investigated Aptuit
(Allendale) Inc. to ensure that the
company’s registration is consistent
with the public interest. The
investigation has included inspection
and testing of the company’s physical
security systems, verification of the
company’s compliance with state and
local laws, and a review of the
company’s background and history.
Therefore, pursuant to 21 U.S.C. 952(a)
and 958(a), and in accordance with 21
CFR 1301.34, the above named company
is granted registration as an importer of
the basic class of controlled substance
listed.
Dated: September 22, 2008.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
[FR Doc. E8–22882 Filed 9–26–08; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Manufacturer of Controlled
Substances; Notice of Registration
By Notice dated March 19, 2008 and
published in the Federal Register on
March 28, 2008 (73 FR 16719), Alltech
Associates Inc., 2051 Waukegan Road,
Deerfield, Illinois 60015, made
application to the Drug Enforcement
Administration (DEA) to be registered as
E:\FR\FM\29SEN1.SGM
29SEN1
Agencies
[Federal Register Volume 73, Number 189 (Monday, September 29, 2008)]
[Notices]
[Page 56613]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E8-22882]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Importer of Controlled Substances; Notice of Registration
By Notice dated June 19, 2008 and published in the Federal Register
on June 27, 2008 (73 FR 36571), Aptuit (Allendale) Inc., 75 Commerce
Drive, Allendale, New Jersey 07401, made application by renewal to the
Drug Enforcement Administration (DEA) to be registered as an importer
of Noroxymorphone (9668), a basic class of controlled substance listed
in schedule II.
The company plans to import the basic class of controlled substance
for clinical trials and research.
No comments or objections have been received. DEA has considered
the factors in 21 U.S.C. 823(a) and 952(a) and determined that the
registration of Aptuit (Allendale) Inc. to import the basic classes of
controlled substances is consistent with the public interest, and with
United States obligations under international treaties, conventions, or
protocols in effect on May 1, 1971, at this time. DEA has investigated
Aptuit (Allendale) Inc. to ensure that the company's registration is
consistent with the public interest. The investigation has included
inspection and testing of the company's physical security systems,
verification of the company's compliance with state and local laws, and
a review of the company's background and history. Therefore, pursuant
to 21 U.S.C. 952(a) and 958(a), and in accordance with 21 CFR 1301.34,
the above named company is granted registration as an importer of the
basic class of controlled substance listed.
Dated: September 22, 2008.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug
Enforcement Administration.
[FR Doc. E8-22882 Filed 9-26-08; 8:45 am]
BILLING CODE 4410-09-P